Completed PHASE4 INTERVENTIONAL 3-arm NCT02761577

A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia

A Prospective Study on Incidence and Prevention of Contrast-induced Nephropathy in Croatia With the Use of Standard Laboratory Measures and Novel Biomarkers

Sponsor: Clinical Hospital Centre Zagreb

Conditions Contrast Media Reaction Kidney Diseases

Interventions N-acetylcysteine Sodium bicarbonate

Updated 5 times since 2017 Last updated: May 2, 2016 Started: Jun 30, 2012 Primary completion: Jul 31, 2013 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02761577, this PHASE4 trial focuses on Contrast Media Reaction and Kidney Diseases and remains completed. Sponsored by Clinical Hospital Centre Zagreb, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Clinical Hospital Centre Zagreb

Data source: Clinical Hospital Centre Zagreb

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.